Triptorelin
Mixed evidenceA long-acting prostate-cancer drug that some communities reinvented as a single-shot hormone restart, resting on a thin anecdote.
What it is
Triptorelin is a modified, long-lasting version of GnRH, the brain hormone that runs reproduction. A chemical tweak makes it survive in the body much longer than the natural hormone, turning minutes into hours. It is an FDA-approved drug for advanced prostate cancer and for a form of early puberty.
How it works
It works in two phases. First it strongly signals the pituitary, causing a flare of LH and FSH. Then, with continued use, the receptor dulls to its signal and sex-hormone production crashes to castrate levels, which is what oncologists want. The community use targets the opposite: the brief flare window, hoping to restart natural testosterone after a cycle.
What people report
- ✦Resoundingly effective for its approved uses: suppressing testosterone in prostate cancer and managing central precocious puberty
- ✦A single shot could in theory prompt a hormonal restart, which is why the idea appeals
- ✦Long-acting depot versions cover 1, 3, and 6-month dosing for medical use
- ✦Approved for endometriosis and fibroids in some regions
Typical use
In medicine it is given as a depot injection every 1–6 months for continuous suppression. The community 'restart' idea centers on the flare in the first 48–72 hours after a single dose, before suppression kicks in.
Dosing reference
The solo-restart story traces to one case report: a single 34-year-old man, one 100 mcg test dose, recovery over a month. That is a narrow anecdote, not a protocol library. Verify any dosing against the fact that the window is far narrower than forums imply.
Reference only — not a recommendation. Verify via primary sources.
Watch for
Used wrong, the suppression phase becomes the outcome, not the recovery. The risk is real: a single misjudged shot can shut down, not restart, your axis. HCG plus a SERM remains the better-characterized historical approach, and WADA bans GnRH agonists for male athletes at all times.
Educational content — not medical advice.